Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.
J Pineal Res
; 59(1): 60-9, 2015 Aug.
Article
in En
| MEDLINE
| ID: mdl-25857269
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Doxorubicin
/
Circadian Rhythm
/
Light
/
Melatonin
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
J Pineal Res
Journal subject:
ENDOCRINOLOGIA
Year:
2015
Type:
Article
Affiliation country:
United States